Literature DB >> 7284975

Localization of mammary tumors in vivo with 131I-labeled Fab fragments of antibodies against mouse mammary epithelial (MME) antigens.

T Wilbanks, J A Peterson, S Miller, L Kaufman, D Ortendahl, R L Ceriani.   

Abstract

The Fab fragments of antibodies against cell-type-specific surface antigens of mouse mammary epithelial cells (MME-antigens) were used to localize mammary tumors successfully. The radioiodine-labeled anti-MME (Fab) was injected into mice carrying simulated mammary metastases, and after 24 hours the amount of label per gram of excised tissue was several times greater in the tumor than in liver, brain, lung, or muscle. Kidney showed considerable accumulation of label but this appeared to be nonspecific. Kinetic studies revealed a rapid elimination of labeled Fab in the urine with only 1% of the injected dose remaining in the entire blood pool after 24 hours. Wit a high-purity germanium camera, mammary tumors were clearly located ty the 131I-labeled anti-MME (Fab), and normalization to 99mTc-pertechnetate distribution in the animal increased the specificity. The density of 131I-label was fourfold greater over the mammary tumor than over comparable areas of the mouse. No accumulation of 131I-anti-MME (Fab) was observed in nonmammary tumors nor in mammary tumors when labeled nonspecific Fab was used. An analogous system using an antihuman mammary epithelial antiserum is being developed for localization of breast metastases in humans.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7284975     DOI: 10.1002/1097-0142(19811015)48:8<1768::aid-cncr2820480813>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Immunoscintigraphy for cancer detection: "a thousand ills require a thousand cures".

Authors:  S H de Bie; T C Ferreira; E K Pauwels; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Localization of human breast tumors grafted in nude mice with a monoclonal antibody directed against a defined cell surface antigen of human mammary epithelial cells.

Authors:  R L Ceriani; M Sasaki; D Orthendahl; L Kaufman
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

3.  Radioimmunotherapy: no news from the newcomer.

Authors:  A M Mello; E K Pauwels; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Use of specific antibody for rapid clearance of circulating blood background from radiolabeled tumor imaging proteins.

Authors:  D Goodwin; C Meares; C Diamanti; M McCall; C Lai; F Torti; M McTigue; B Martin
Journal:  Eur J Nucl Med       Date:  1984

5.  Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice.

Authors:  M K Haseman; D A Goodwin; C F Meares; M S Kaminski; T G Wensel; M J McCall; R Levy
Journal:  Eur J Nucl Med       Date:  1986

6.  Dose-dependent localisation and potential for therapy of F(ab')2 fragments against CEA studied in a human tumour xenograft model.

Authors:  G T Rogers; P J Harwood; R B Pedley; J Boden; K D Bagshawe
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640

7.  Development and characterization of chimeric anti-carcinoembryonic antigen monoclonal antibodies and their Fab fragments.

Authors:  T Kamigaki; H Ohyanagi; M Yamamoto; T Kaneda; T Goto; T Ohmura; K Yokoyama; Y Saitoh
Journal:  Jpn J Cancer Res       Date:  1994-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.